Search
for
Sort by
Research 541–570 of 634
- Cardiometabolic comorbidities associated with androgenetic alopecia: Findings from a sex-stratified, propensity-matched national cohort
- PCOS and Cardiometabolic Health over the Reproductive Years
- A Multidisciplinary Lifestyle Intervention for Women with Polycystic Ovary Syndrome: The Role of a Pulse-Based Diet and Aerobic Exercise on Reproductive, Cardio-Metabolic, and Quality of Life Outcomes
- Cardiometabolic aspects of the polycystic ovary syndrome
- Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome
- Impaired Cardiometabolic Effects of Bromocriptine in Men With Early‐Onset Androgenic Alopecia
- Impact of lisinopril on cardiometabolic risk factors in men with hypertension and early-onset androgenetic alopecia
- Anabolic-Androgenic Steroids and Cardiometabolic Derangements
- Facial Appearance and Markers of Cardiometabolic Risk in Healthy Adult Men
- Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study
- Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
- Knowledge gaps and health practices related to polycystic ovary syndrome among women in Southwestern Saudi Arabia: a cross-sectional study
- A practical guide on Polyendocrine Metabolic Ovarian Syndrome (PMOS) for Clinicians
- Population-level risk of erectile dysfunction after finasteride use for androgenetic alopecia: a national cohort analysis
- REVIEW ON SEASONAL INCIDENCE OF PSORIASIS EXACERBATIONS DURING WINTER IN INDIA: CLINICAL INSIGHTS AND OBSERVATIONS
- 24. 力発揮および操作性からみた下肢運動の一側優位性(神経・感覚,一般口演,第63回日本体力医学会大会)
- AMALAKI (EMBLICA OFFICINALIS GAERTN.): AN INTEGRATIVE REVIEW AND META-ANALYSIS OF CLASSICAL AYURVEDIC PERSPECTIVES AND MODERN CLINICAL EVIDENCE
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks
- 73323 Androgenic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
- Why cells need iron: a compendium of iron utilisation
- Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- Metabolic aging and cutaneous markers of metabolic syndrome: a narrative review
- 268 Male-pattern baldness and its association with coronary heart disease
- Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia
- Epicardial fat thickness in children with classic congenital adrenal hyperplasia